微信公众号
证券之星APP
| 报告期 | 净资产收益率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 6.77% | -3.7% | -68.97% | 4/69 | 2.26% | 天目药业 | 9.27% | 行业排名> |
| 2024-12-31 | 21.82% | -5.54% | 15.33% | 3/69 | 3.28% | 天目药业 | 22.26% | 行业排名> |
| 2024-09-30 | 18.92% | -3.27% | 53.7% | 2/69 | 3.08% | 羚锐制药 | 20.44% | 行业排名> |
| 2024-06-30 | 12.31% | -5.53% | 75.11% | 2/69 | 0.67% | 羚锐制药 | 13.25% | 行业排名> |
| 2024-03-31 | 7.03% | 7% | -69.57% | 1/69 | 1.53% | 片仔癀 | 7.03% | 行业排名> |
| 2023-12-31 | 23.1% | -1.87% | 18.1% | 1/69 | 0.11% | 片仔癀 | 23.1% | 行业排名> |
| 2023-09-30 | 19.56% | -0.66% | 50.12% | 3/69 | 7.26% | 太极集团 | 22.08% | 行业排名> |
| 2023-06-30 | 13.03% | 2.2% | 98.33% | 4/69 | 4.93% | 太极集团 | 17.13% | 行业排名> |
| 2023-03-31 | 6.57% | -4.51% | -72.09% | 6/69 | 3.21% | 以岭药业 | 10.43% | 行业排名> |
| 2022-12-31 | 23.54% | -14.06% | 19.55% | 1/69 | 6.65% | *ST吉药 | 72.63% | 行业排名> |
| 2022-09-30 | 19.69% | -14.91% | 54.43% | 1/69 | 5.16% | 片仔癀 | 23.54% | 行业排名> |
| 2022-06-30 | 12.75% | -3.63% | 85.32% | 1/69 | 3.2% | 片仔癀 | 19.69% | 行业排名> |
| 2022-03-31 | 6.88% | 3.93% | -74.88% | 1/69 | 2.18% | 片仔癀 | 12.75% | 行业排名> |
| 2021-12-31 | 27.39% | 24.9% | 18.37% | 1/69 | 4.54% | 片仔癀 | 6.88% | 行业排名> |
| 2021-09-30 | 23.14% | 24.68% | 74.91% | 1/69 | 7.54% | 片仔癀 | 27.39% | 行业排名> |
| 2021-06-30 | 13.23% | 8.8% | 99.85% | 1/69 | 4.68% | 片仔癀 | 23.14% | 行业排名> |
| 2021-03-31 | 6.62% | -3.07% | -69.81% | 4/69 | 2.7% | 片仔癀 | 13.23% | 行业排名> |
| 2020-12-31 | 21.93% | -5.88% | 18.16% | 2/69 | 0.1% | *ST长药 | 7.37% | 行业排名> |
| 2020-09-30 | 18.56% | -5.74% | 52.63% | 2/69 | 6.79% | 沃华医药 | 22.84% | 行业排名> |
| 2020-06-30 | 12.16% | -11.37% | 78.04% | 2/69 | 3.75% | 沃华医药 | 19.47% | 行业排名> |
| 2020-03-31 | 6.83% | -11.07% | -70.69% | 2/69 | 2.14% | 沃华医药 | 12.7% | 行业排名> |
| 2019-12-31 | 23.3% | -5.13% | 18.33% | 4/69 | 5.86% | 济川药业 | 7.33% | 行业排名> |
| 2019-09-30 | 19.69% | -4.42% | 43.51% | 2/69 | 7.3% | 济川药业 | 27.43% | 行业排名> |
| 2019-06-30 | 13.72% | 0% | 78.65% | 2/69 | 4.72% | 济川药业 | 23.05% | 行业排名> |
| 2019-03-31 | 7.68% | 0.92% | -68.73% | 3/69 | 2.92% | 济川药业 | 15.79% | 行业排名> |
| 2018-12-31 | 24.56% | 20.87% | 19.22% | 3/69 | 7.87% | 华润三九 | 10.23% | 行业排名> |
| 2018-09-30 | 20.6% | 15.8% | 50.15% | 2/69 | 8.02% | 济川药业 | 32.79% | 行业排名> |
| 2018-06-30 | 13.72% | 22.06% | 80.29% | 2/69 | 5.03% | 济川药业 | 27.55% | 行业排名> |
| 2018-03-31 | 7.61% | 21.18% | -62.55% | 2/69 | 2.75% | 济川药业 | 17.62% | 行业排名> |
| 2017-12-31 | 20.32% | 28.69% | 14.22% | 6/69 | 9.93% | 济川药业 | 10.07% | 行业排名> |
| 2017-09-30 | 17.79% | 21.52% | 58.27% | 2/69 | 8.39% | ST葫芦娃 | 46.01% | 行业排名> |
| 2017-06-30 | 11.24% | 20.34% | 78.98% | 2/69 | 5.24% | 济川药业 | 24.2% | 行业排名> |
| 2017-03-31 | 6.28% | 38.33% | -60.23% | 3/69 | 2.62% | *ST大药 | 15.31% | 行业排名> |
| 2016-12-31 | 15.79% | 3.95% | 7.86% | 14/69 | 10.02% | 济川药业 | 14.64% | 行业排名> |
| 2016-09-30 | 14.64% | 19.51% | 56.75% | 7/69 | 9.32% | 济川药业 | 7.64% | 行业排名> |
| 2016-06-30 | 9.34% | 13.21% | 105.73% | 9/69 | 5.04% | 维康药业 | 38.23% | 行业排名> |
| 2016-03-31 | 4.54% | 16.71% | -70.11% | 9/69 | 4.1% | 太极集团 | 58.41% | 行业排名> |
| 2015-12-31 | 15.19% | 4.04% | 24% | 23/69 | 11.34% | 新光药业 | 16.54% | 行业排名> |
| 2015-09-30 | 12.25% | 1.16% | 48.48% | 13/69 | 8.44% | 太极集团 | 71.6% | 行业排名> |
| 2015-06-30 | 8.25% | -4.4% | 112.08% | 17/69 | 5.48% | 维康药业 | 48.67% | 行业排名> |
| 2015-03-31 | 3.89% | -18.11% | -73.36% | 17/69 | 2.9% | 济川药业 | 21.37% | 行业排名> |